Prognostic Value of KRAS Exon 3 and Exon 4 Mutations in Colorectal Cancer Patients

Background: The clinical significance of KRAS exon 3/4 mutations in colorectal cancer (CRC) remains unclear. We aimed to assess the prognostic value of KRAS exons 3 and 4 mutations to determine the necessity for their testing. Methods: KRAS mutations in exon 2/3/4 were evaluated in 1816 stage I-IV p...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Tianan, Wu, Yuchen, Huang, Dan, Jin, Yutong, Sheng, Weiqi, Cai, Sanjun, Zhou, Xiaoyan, Zhu, Xiaoli, Liu, Fangqi, Xu, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317521/
https://www.ncbi.nlm.nih.gov/pubmed/34335949
http://dx.doi.org/10.7150/jca.59193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317521/
https://www.ncbi.nlm.nih.gov/pubmed/34335949
http://dx.doi.org/10.7150/jca.59193

Ejemplares similares